Pages that link to "Q76383399"
Jump to navigation
Jump to search
The following pages link to Neuroprotective effects of a novel poly(ADP-ribose) polymerase-1 inhibitor, 2-[3-[4-(4-chlorophenyl)-1-piperazinyl] propyl]-4(3H)-quinazolinone (FR255595), in an in vitro model of cell death and in mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (Q76383399):
Displaying 17 items.
- Bioenergetic metabolites regulate base excision repair-dependent cell death in response to DNA damage (Q33598840) (← links)
- Paeoniflorin attenuates neuroinflammation and dopaminergic neurodegeneration in the MPTP model of Parkinson's disease by activation of adenosine A1 receptor (Q35545909) (← links)
- Parthanatos, a messenger of death (Q35670138) (← links)
- Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors (Q36111918) (← links)
- Therapeutic applications of PARP inhibitors: anticancer therapy and beyond (Q36853236) (← links)
- NAD+ and NADH in neuronal death (Q37015565) (← links)
- The Short Isoform of DNAJB6 Protects against 1-Methyl-4-phenylpridinium Ion-Induced Apoptosis in LN18 Cells via Inhibiting Both ROS Formation and Mitochondrial Membrane Potential Loss. (Q37661170) (← links)
- Poly(ADP-ribose) polymerase-1 (PARP-1) and its therapeutic implications (Q37773040) (← links)
- The Biochemical and Cellular Basis for Nutraceutical Strategies to Attenuate Neurodegeneration in Parkinson’s Disease (Q37845675) (← links)
- Chronic oxidative damage together with genome repair deficiency in the neurons is a double whammy for neurodegeneration: Is damage response signaling a potential therapeutic target? (Q38963019) (← links)
- Metabolic Dysfunction in Parkinson's Disease: Bioenergetics, Redox Homeostasis and Central Carbon Metabolism. (Q39199926) (← links)
- Parp1 activation in mouse embryonic fibroblasts promotes Pol beta-dependent cellular hypersensitivity to alkylation damage (Q39497145) (← links)
- Variable toxicological response to the loss of OXPHOS through 1-methyl-4-phenylpyridinium-induced mitochondrial damage and anoxia in diverse neural immortal cell lines (Q39713426) (← links)
- Parp and cell death or protection in rat primary astroglial cell cultures under LPS/IFNgamma induced proinflammatory conditions (Q39945296) (← links)
- The neuroprotective effect of nicotine in Parkinson's disease models is associated with inhibiting PARP-1 and caspase-3 cleavage (Q47146624) (← links)
- PPARβ/δ Agonist Provides Neuroprotection by Suppression of IRE1α-Caspase-12-Mediated Endoplasmic Reticulum Stress Pathway in the Rotenone Rat Model of Parkinson's Disease (Q48087394) (← links)
- Biological effects of MC2050, a quinazoline-based PARP-1 inhibitor, in human neuroblastoma and EBV-positive Burkitt's lymphoma cells (Q83510539) (← links)